Friday, March 3, 2023

WIRTW #663: the “growth” edition

Growth comes in many forms.  For my son, it came in the form of a daily injection of growth hormones since the age of seven. 

Because of his Noonan Syndrome, he's genetically predisposed to being short statured. That fact that I'm 5' 7" and his mom 4' 11" also didn't help his cause. Donovan was barely on the growth chart, and his doctors projected his full adult height at a mere 5' or 5' 1". Shortly after his 7th birthday he took his first dose of growth hormones, a daily injection. It was his decision after he was deemed not tall enough for a new bike he wanted. His endocrinologist at the time thought my wife and I were out of our minds for letting Donovan decide if and when to start treatment. To us, however, if he's the one taking the needle, he should have some say in the if and the when. 

Earlier this week Donovan took his final dose, a decision made by his current endocrinologist that he's received all of the possible medical benefit from the more than 2,700 injections he took over nearly eight years.

He's now close to 5' 7", with another inch or two still to grow. That's what I call growth.

Here's what I read this week that you should read, too.

The Legalities of Screening Candidates’ Social Media — via me, writing at

Starbucks Faces New Front in Its Labor Disputes: White-Collar Workers — via Bloomberg

When Should You Fire An Employee? — via Dan Schwartz's Connecticut Employment Law Blog

NLRB Makes Employers Liable For Damages For Direct and Foreseeable Harms Screw You Guys, I'm 

Senators ask U.S. Chamber of Commerce for information about their objection to the FTC's proposed ban Fair Competition Law

Working for the Jerk Partner as a Young Associate Attorney at Work

Antisemitism at work: How the face of hate is changing HR Dive

No job description? No problem. See why this employer had no duty to accommodate. Eric Meyer's The Employer Handbook Blog